Skip to main content

Animations

MJFF Publications

871 - 880 of 8571 Results
Title
Year
  • Year
  • 2018
  • 2025
  • 2025
  • 2023
  • 2025
  • 2020
  • 2023
  • 2023
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: β2‐adrenoreceptor medications and risk of Parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25341
    Best OA location URL:
    Citation Count: 72
  • Summary Details
    OPEN
    Title: A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stage
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.107018
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Local Regulation of Striatal Dopamine Release Shifts from Predominantly Cholinergic in Mice to GABAergic in Macaques
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1523/jneurosci.1692-24.2025
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Prevalence and impact of neuropsychiatric symptoms in normal aging and neurodegenerative syndromes: A population‐based study from Latin America
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.13384
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Radiosynthesis, In Vitro Characterization, and In Vivo PET Neuroimaging of [18F]F-4 for Tau Protein: A First-in-Human PET Study
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acschemneuro.4c00866
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa096
    Citation Count: 178
  • Summary Details
    OPEN
    Title: Cell-free RNA signatures predict Alzheimer’s disease
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.isci.2023.108534
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Brain Degeneration in Synucleinopathies Based on Analysis of Cognition and Other Nonmotor Features: A Multimodal Imaging Study
    Journal Name: Biomedicines
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biomedicines11020573
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Putting participants and study partners FIRST when clinical trials end early
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.12732
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Heterogeneous digital biomarker integration out-performs patient self-reports in predicting Parkinson’s disease
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-022-03002-x
    Citation Count: 27
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.